This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Obamacare Complaints May Be Smokescreen for Other Problems

Editor's note: As part of our partnership with Nightly Business Report, TheStreet's Debra Borchardt will join NBR Monday (check local listings) as she questions whether companies that cry over the health care mandate are really covering up other problems.

NEW YORK ( TheStreet -- Companies sounding the alarm about rising health care costs in the wake of President Barak Obama winning a second term in The White House may be more motivated by politics than facts.

Investors should also consider that the political complaints could be used to mask other, more important problems within the company.

Papa John's (PZZA - Get Report), for example, said it plans to reduce the hours of some employees in order to have more part-time workers than full-time workers. In a conference call with shareholders, CEO John Shnatter estimated the changes to health care laws could add as much as 20 cents to the cost of a pizza. Rather than raising prices, he's opting to penalize his employees.

Now speaking from the personal experience of having a pizza franchise in my family at one time (not Papa John's), you want more full-time stable employees rather than a roster of part-timers. It's a scheduling nightmare and they have less loyalty.

A quick review of where the costs are rising for Papa John's in its latest quarter tells another story. General and administrative costs have been affected by higher management incentive costs and expenses related to the company's operators conference. Salary costs rose because of higher bonuses paid to managers. Advertising costs were higher and the only cost that went down was cheese.

Medical device manufacturer Stryker (SYK - Get Report) has also chafed at Obamacare. The company said it plans to close its New York facility and cut 96 jobs in December. Its response to the medical device tax is to slash 5% of its workforce, or 1,170 jobs. It blames the tax for all these changes.

Stryker, though, is also facing numerous lawsuits on hip products, patents, subpoenas from the Department of Justice and even its own shareholders. The company also recently had to recall its Neptune waste management product.

Stryker also chooses to ignore that, even before the health care mandate looked like it would live, that the third quarter of 2012 was the fourth consecutive quarter of slowing sales growth. Stryler is losing market share in Europe and has seen slower sales of capital equipment in the United States. However, blaming politics is much easier and diverts attention away from the real problems. Stryker is down 3% over the past three months, although it's still positive for the year, returning 6%.
1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
DRI $63.48 -0.20%
PZZA $55.62 -3.47%
SBUX $56.25 -1.59%
SYK $109.17 -0.70%
AAPL $95.18 1.64%


Chart of I:DJI
DOW 17,750.91 -140.25 -0.78%
S&P 500 2,063.37 -18.06 -0.87%
NASDAQ 4,763.2240 -54.37 -1.13%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs